# Acadia Pharmaceuticals Inc: filings

ACAD · Nasdaq · CIK 1070494 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/acad.md) · [Financials](/companies/acad/financials.md) · [Filings](/companies/acad/filings.md) · [Insiders](/companies/acad/insiders.md)

## Reports and events: 302 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 512, 8-K 193, SC 13G/A 73, 10-Q 53, 3 30, CT ORDER 28, S-8 POS 19, 10-K 18, DEF 14A 18, SC 13G 18, S-8 17, 144 16, SC 13D/A 16, 424B5 14, ARS 10, S-3ASR 6, 4/A 5, DEFA14A 5, EFFECT 5, S-3 5, SCHEDULE 13G/A 4, UPLOAD 3, 424B3 2, 8-K/A 2, CORRESP 2, D 2, DEFR14A 2, PRE 14A 2, SEC STAFF LETTER 2, 3/A 1, 5 1, SC 13D 1, SCHEDULE 13D/A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 16:51 ET | [8-K](/filings/0001193125-26-430596.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-430596 |
| 2026-09-24 | 17:11 ET | [8-K](/filings/0001193125-26-401157.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-401157 |
| 2026-09-11 | 17:15 ET | [8-K](/filings/0001193125-26-389400.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-389400 |
| 2026-08-05 | 18:12 ET | [10-Q](/filings/0001193125-26-333243.md) | Quarterly report, period 2026-06-30 | 0001193125-26-333243 |
| 2026-08-04 | 16:16 ET | [8-K](/filings/0001193125-26-332858.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-332858 |
| 2026-05-29 | 16:05 ET | [8-K](/filings/0001193125-26-248242.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-248242 |
| 2026-05-07 | 19:50 ET | [10-Q](/filings/0001193125-26-209731.md) | Quarterly report, period 2026-03-31 | 0001193125-26-209731 |
| 2026-05-06 | 16:50 ET | [8-K](/filings/0001193125-26-209253.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-209253 |
| 2026-05-01 | 17:34 ET | [8-K](/filings/0001193125-26-197957.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-197957 |
| 2026-04-24 | 18:05 ET | [DEF 14A](/filings/0001193125-26-174163.md) | Proxy statement, period 2026-05-29 | 0001193125-26-174163 |
| 2026-03-05 | 20:56 ET | [8-K](/filings/0001193125-26-092213.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-092213 |
| 2026-02-26 | 18:59 ET | [SCHEDULE 13D/A](/filings/0001104659-26-020778.md) | Ownership report, active investor, amended | 0001104659-26-020778 |
| 2026-02-26 | 19:22 ET | [10-K](/filings/0001193125-26-072519.md) | Annual report, period 2025-12-31 | 0001193125-26-072519 |
| 2026-02-25 | 16:20 ET | [8-K](/filings/0001193125-26-071674.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-071674 |
| 2026-01-13 | 15:58 ET | [8-K](/filings/0001193125-26-011706.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-011706 |
| 2025-11-06 | 18:47 ET | [10-Q](/filings/0001193125-25-267453.md) | Quarterly report, period 2025-09-30 | 0001193125-25-267453 |
| 2025-11-05 | 16:13 ET | [8-K](/filings/0001193125-25-266959.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-266959 |
| 2025-11-03 | 16:23 ET | [8-K](/filings/0001193125-25-262610.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-262610 |
| 2025-08-07 | 17:53 ET | [10-Q](/filings/0000950170-25-104295.md) | Quarterly report, period 2025-06-30 | 0000950170-25-104295 |
| 2025-08-06 | 16:18 ET | [8-K](/filings/0000950170-25-104092.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104092 |
| 2025-06-10 | 16:06 ET | [8-K](/filings/0001193125-25-138452.md) | 8.01 Other events | 0001193125-25-138452 |
| 2025-05-29 | 16:06 ET | [8-K](/filings/0001193125-25-130620.md) | 5.07 Shareholder vote results | 0001193125-25-130620 |
| 2025-05-20 | 16:31 ET | [8-K](/filings/0001193125-25-123175.md) | 1.01 Entry into a material agreement; 8.01 Other events | 0001193125-25-123175 |
| 2025-05-08 | 21:15 ET | [10-Q](/filings/0000950170-25-066231.md) | Quarterly report, period 2025-03-31 | 0000950170-25-066231 |
| 2025-05-07 | 16:13 ET | [8-K](/filings/0000950170-25-065672.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-065672 |
| 2025-04-25 | 16:49 ET | [DEF 14A](/filings/0000950170-25-058827.md) | Proxy statement, period 2025-05-29 | 0000950170-25-058827 |
| 2025-04-16 | 16:15 ET | [8-K](/filings/0001193125-25-082809.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-25-082809 |
| 2025-02-27 | 17:26 ET | [10-K](/filings/0000950170-25-029253.md) | Annual report, period 2024-12-31 | 0000950170-25-029253 |
| 2025-02-26 | 16:15 ET | [8-K](/filings/0000950170-25-027759.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-027759 |
| 2024-12-11 | 16:22 ET | [8-K](/filings/0001193125-24-275595.md) | 2.01 Completion of an acquisition or disposition | 0001193125-24-275595 |
| 2024-11-20 | 16:30 ET | [8-K](/filings/0001193125-24-262556.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-262556 |
| 2024-11-07 | 17:41 ET | [10-Q](/filings/0000950170-24-122513.md) | Quarterly report, period 2024-09-30 | 0000950170-24-122513 |
| 2024-11-06 | 16:14 ET | [8-K](/filings/0000950170-24-122322.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122322 |
| 2024-09-23 | 16:34 ET | [8-K](/filings/0001193125-24-223726.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-223726 |
| 2024-08-07 | 19:48 ET | [10-Q](/filings/0000950170-24-092163.md) | Quarterly report, period 2024-06-30 | 0000950170-24-092163 |
| 2024-08-06 | 16:13 ET | [8-K](/filings/0000950170-24-091826.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-091826 |
| 2024-05-29 | 17:23 ET | [8-K](/filings/0001193125-24-149336.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-24-149336 |
| 2024-05-09 | 19:13 ET | [10-Q](/filings/0000950170-24-056077.md) | Quarterly report, period 2024-03-31 | 0000950170-24-056077 |
| 2024-05-08 | 16:10 ET | [8-K](/filings/0000950170-24-055647.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-055647 |
| 2024-04-26 | 16:21 ET | [DEF 14A](/filings/0000950170-24-049182.md) | Proxy statement, period 2024-05-29 | 0000950170-24-049182 |
| 2024-03-11 | 16:05 ET | [8-K](/filings/0001193125-24-064791.md) | 8.01 Other events | 0001193125-24-064791 |
| 2024-02-28 | 18:01 ET | [10-K](/filings/0000950170-24-021473.md) | Annual report, period 2023-12-31 | 0000950170-24-021473 |
| 2024-02-27 | 16:16 ET | [8-K](/filings/0000950170-24-021169.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-021169 |
| 2024-01-31 | 21:55 ET | [8-K](/filings/0001193125-24-019903.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-019903 |
| 2023-11-21 | 17:11 ET | [8-K](/filings/0001193125-23-281574.md) | 8.01 Other events | 0001193125-23-281574 |
| 2023-11-03 | 18:33 ET | [10-Q](/filings/0000950170-23-058436.md) | Quarterly report, period 2023-09-30 | 0000950170-23-058436 |
| 2023-11-02 | 16:21 ET | [8-K](/filings/0000950170-23-058254.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-058254 |
| 2023-08-03 | 19:29 ET | [10-Q](/filings/0000950170-23-037458.md) | Quarterly report, period 2023-06-30 | 0000950170-23-037458 |
| 2023-08-02 | 16:23 ET | [8-K](/filings/0000950170-23-037216.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-037216 |
| 2023-07-18 | 16:01 ET | [8-K](/filings/0001193125-23-188839.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-188839 |

Page 1 of 7. [Older](/companies/acad/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 20:22 ET. No prices; not investment advice.